Evidence map›Paper›PMID 20409363›Full record

ArticleEmerging infectious diseases2010

Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico.

Richard S Garfein, Rafael Laniado-Laborin, Timothy C Rodwell, Remedios Lozada, Robert Deiss, Jose Luis Burgos, Jazmine Cuevas-Mota, Paris Cerecer, Kathleen Moser, Maria Luisa Volker and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Tuberculosis testing among populations with high HIV risk in Tijuana, Baja California, Mexico.Revista panamericana de salud publica = Pan American journal of public health · 2012
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Richard S GarfeinUniversity of California San Diego School of Medicine, San Diego, California, USA.
Rafael Laniado-Laborin
Timothy C Rodwell
Remedios Lozada
Robert Deiss
Jose Luis Burgos
Jazmine Cuevas-Mota
Paris Cerecer
Kathleen Moser
Maria Luisa Volker
Steffanie A Strathdee
University of California, San Diego · USNational Public Health Laboratory · NPSociedad Española de Medicina Interna · ES

Funding

HOPE Training GrantT32AI007384 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sara Gianella Weibel, Scott L Letendre · 1990 to 2026
$9.7M
Training Program in Substance Use, HIV and Related InfectionsT32DA023356 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Natasha Martin, Steffanie A Strathdee · 2007 to 2026
$7.8M
Impact of Drug Policy Reform on the HIV Risk Environment among IDUs in TijuanaR37DA019829 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2010 to 2019
$6.7M
Epidemiologic Study on Changing HIV Risks Among FSW-IDUs on the Mexico-US BorderR01DA023877 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2008 to 2012
$3.3M
The Role of Economic Evaluation in Translating HIV/AIDS Behavioral InterventionsK01MH095680 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BURGOS, JOSE LUIS · 2012 to 2016
$902k
Binational Transmission of Multidrug-Resistant Tuberculosis, California & MexicoK01AI083784 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RODWELL, TIMOTHY CHARLES · 2009 to 2012
$487k
NIAID NIH HHS AI083784-01NIAID NIH HHS K01 AI083784NIAID NIH HHS T32 AI007384NIAID NIH HHS T32-AI07384NIDA NIH HHS DA023877-S2NIDA NIH HHS R01 DA023877NIDA NIH HHS R37 DA019829NIDA NIH HHS T32 DA023356NIDA NIH HHS T32-DA023356NIMHD NIH HHS L60 MD001952NIMH NIH HHS K01 MH095680
6 · The paper itself

Abstract

Because there is little routine tuberculosis (TB) screening in Mexico, the prevalence of latent TB infection (LTBI) is unknown. In the context of an increasing HIV epidemic in Tijuana, Mexico, understanding prevalence of LTBI to anticipate emergence of increased LTBI reactivation is critical. Therefore, we recruited injection drug users, noninjection drug users, female sex workers, and homeless persons for a study involving risk assessment, rapid HIV testing, and TB screening. Of 503 participants, the overall prevalences of TB infection, HIV infection, and TB/HIV co-infection were 57%, 4.2%, and 2.2%, respectively; no significant differences by risk group (p>0.05) were observed. Two participants had TB (prevalence 398/100,000). Incarceration in Mexico (odds ratio [OR] 2.28), age (OR 1.03 per year), and years lived in Tijuana (OR 1.02 per year) were independently associated with TB infection (p<0.05). Frequent LTBI in marginalized persons may lead to increases in TB as HIV spreads.

Indexed as

AdultAge FactorsDrug UsersFemaleHIVHIV InfectionsHumansIll-Housed PersonsLatent TuberculosisMaleMexicoMycobacterium tuberculosisPrevalencePrisonersRiskRisk Factors

Identifiers

PMID20409363
PMCPMC2953999
OpenAlexW2127180629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.